SCHEMBL19769300

SCHEMBL19769300

Cc1ccc2c(c1)Oc1cc(OC(=O)C(C)(C)C)ccc1C21OC(=O)c2ccc(C(=O)NCCCCCC(=O)N3CCC(C)(CO)CC3)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP14 P50281 1/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ GSTP1 P09211 1/20 0.36
▸ ITPR3 Q14573 1/20 0.36
▸ KCNH2 Q12809 2/20 0.35
▸ NT5E P21589 1/20 0.35
▸ HDAC6 Q9UBN7 2/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ ALB P02768 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ P2RY14 Q15391 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19769279 0.95 MMP14 (0.43) MMP14MEN1USP2ALDH1A1LMNA
SCHEMBL19769317 0.91 MMP14 (0.38) MMP14MEN1USP2ALDH1A1LMNA
SCHEMBL19769316 0.86 MMP14 (0.42) MMP14MEN1USP2ALDH1A1LMNA
SCHEMBL19769298 0.78 KCNH2 (0.46) MMP14ALDH1A1KCNH2HDAC6JAK2
SCHEMBL23758534 0.78 GSTP1 (0.44) MMP14MEN1USP2ALDH1A1LMNA
SCHEMBL6879196 0.78 GSTP1 (0.50) MMP14MEN1USP2ALDH1A1LMNA
SCHEMBL12563930 0.77 MEN1 (0.52) MEN1USP2ALDH1A1LMNAMAPT
SCHEMBL9965287 0.76 ALB (0.39) MMP14MEN1USP2ALDH1A1LMNA
SCHEMBL10082966 0.76 PDK2 (0.40) MMP14MEN1USP2ALDH1A1LMNA
SCHEMBL4403233 0.75 GSTP1 (0.41) MMP14MEN1USP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159458-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES AM CHEMICALS LLC (US) 2023-05-25 — — US disclosed
US-20180016232-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES AM CHEMICALS LLC (US) 2018-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159458-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES NCL, PAICS, RTCB MMP14 4739/4885MEN1 2389/4885USP2 4525/4885
US-20180016232-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES NCL, PAICS, RTCB MMP14 4739/4885MEN1 2389/4885USP2 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback